GASTROESOPHAGEAL JUNCTION
Clinical trials for GASTROESOPHAGEAL JUNCTION explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL JUNCTION trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL JUNCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced stomach cancer: experimental drug cocktail trial opens
Disease control Recruiting nowThis study is testing new drug combinations for people with advanced stomach or esophageal cancer that cannot be removed by surgery. Researchers will give 160 participants experimental drugs along with standard chemotherapy and immunotherapy to see if they are safe and effective.…
Matched conditions: GASTROESOPHAGEAL JUNCTION
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for tough stomach cancers: trial tests Cutting-Edge drug combos
Disease control Recruiting nowThis study is testing whether adding new targeted drugs to standard chemotherapy works better for people with advanced stomach or esophageal cancer that has worsened after initial treatment. It will enroll 210 participants to compare different drug combinations, focusing on safet…
Matched conditions: GASTROESOPHAGEAL JUNCTION
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New scan could spot hidden cancer spread more accurately
Diagnosis Recruiting nowThis study is testing a new type of PET/CT scan called [¹⁸F]FAPI-74 to see if it can better detect when stomach or esophageal cancer has spread to other parts of the body. The trial will involve 200 adults with these cancers who are being evaluated for treatment. Researchers will…
Matched conditions: GASTROESOPHAGEAL JUNCTION
Phase: PHASE3 • Sponsor: SOFIE • Aim: Diagnosis
Last updated Mar 20, 2026 14:48 UTC